TFF PHARMACEUTICALS, INC. Other Comprehensive Income (Loss), Tax
TFF PHARMACEUTICALS, INC. reported Other Comprehensive Income (Loss), Tax of -$5.03 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossTax · last filed 2023-08-14
- TFF PHARMACEUTICALS, INC. other comprehensive income (loss), tax for the quarter ending 2023-06-30 was -$5.03M.
- TFF PHARMACEUTICALS, INC. other comprehensive income (loss), tax for the quarter ending 2023-03-31 was -$7.07M.
- TFF PHARMACEUTICALS, INC. other comprehensive income (loss), tax for the quarter ending 2022-12-31 was -$7.30M.
- TFF PHARMACEUTICALS, INC. other comprehensive income (loss), tax for the quarter ending 2022-09-30 was -$7.38M.
- TFF PHARMACEUTICALS, INC. other comprehensive income (loss), tax for fiscal 2022 was -$31.86M.
- TFF PHARMACEUTICALS, INC. other comprehensive income (loss), tax for fiscal 2021 was -$31.04M.
- TFF PHARMACEUTICALS, INC. other comprehensive income (loss), tax for fiscal 2020 was -$18.62M.
- TFF PHARMACEUTICALS, INC. other comprehensive income (loss), tax for fiscal 2019 was -$11.87M.
| Period end | Other Comprehensive Income (Loss), Tax 3 month | Other Comprehensive Income (Loss), Tax 6 month | Other Comprehensive Income (Loss), Tax 9 month | Other Comprehensive Income (Loss), Tax 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$5.03M 10-Q · filed 2023-08-14 | -$12.10M 10-Q · filed 2023-08-14 | -$19.40M derived: sum of 3 quarters · filed 2023-08-14 | -$26.78M derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | -$7.07M 10-Q · filed 2023-05-11 | -$14.37M derived: sum of 2 quarters · filed 2023-05-11 | -$21.75M derived: sum of 3 quarters · filed 2023-05-11 | -$30.60M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | -$7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$14.68M derived: sum of 2 quarters · filed 2023-03-31 | -$23.53M derived: sum of 3 quarters · filed 2023-08-14 | -$31.86M 10-K · filed 2023-03-31 |
| 2022-09-30 | -$7.38M 10-Q · filed 2022-11-14 | -$16.23M derived: sum of 2 quarters · filed 2023-08-14 | -$24.56M 10-Q · filed 2022-11-14 | -$34.49M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | -$8.85M 10-Q · filed 2023-08-14 | -$17.18M 10-Q · filed 2023-08-14 | -$27.11M derived: sum of 3 quarters · filed 2023-08-14 | -$35.84M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$8.33M 10-Q · filed 2023-05-11 | -$18.26M derived: sum of 2 quarters · filed 2023-05-11 | -$26.99M derived: sum of 3 quarters · filed 2023-05-11 | -$31.67M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$9.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$18.66M derived: sum of 2 quarters · filed 2023-03-31 | -$23.34M derived: sum of 3 quarters · filed 2023-03-31 | -$31.04M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$8.73M 10-Q · filed 2022-11-14 | -$13.42M derived: sum of 2 quarters · filed 2022-11-14 | -$21.11M 10-Q · filed 2022-11-14 | -$26.99M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$4.68M 10-Q · filed 2022-08-11 | -$12.38M 10-Q · filed 2022-08-11 | -$18.25M derived: sum of 3 quarters · filed 2022-08-11 | -$23.34M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$7.69M 10-Q · filed 2022-05-11 | -$13.57M derived: sum of 2 quarters · filed 2022-05-11 | -$18.66M derived: sum of 3 quarters · filed 2022-05-11 | -$22.49M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$10.97M derived: sum of 2 quarters · filed 2022-03-24 | -$14.80M derived: sum of 3 quarters · filed 2022-03-24 | -$18.62M 10-K · filed 2022-03-24 |
| 2020-09-30 | -$5.09M 10-Q · filed 2021-11-15 | -$8.92M derived: sum of 2 quarters · filed 2021-11-15 | -$12.74M 10-Q · filed 2021-11-15 | -$16.63M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$3.84M 10-Q · filed 2021-08-12 | -$7.65M 10-Q · filed 2021-08-12 | -$11.55M derived: sum of 3 quarters · filed 2021-08-12 | -$14.64M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$3.82M 10-Q · filed 2021-05-13 | -$7.71M derived: sum of 2 quarters · filed 2021-05-13 | -$10.81M derived: sum of 3 quarters · filed 2021-05-13 | -$13.28M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$3.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$6.99M derived: sum of 2 quarters · filed 2021-03-10 | -$9.47M derived: sum of 3 quarters · filed 2021-03-10 | -$11.87M 10-K · filed 2021-03-10 |
| 2019-09-30 | -$3.10M 10-Q · filed 2020-11-05 | -$5.57M derived: sum of 2 quarters · filed 2020-11-05 | -$7.98M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | -$2.48M 10-Q · filed 2020-08-13 | -$4.88M 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | -$2.18M 10-Q · filed 2020-05-14 |